Abstract
Objective:
Rotator cuff tendinopathy secondary to subacromial impingement (SAI) is typically treated with a combination of physical therapy, oral anti-inflammatory medications, and local corticosteroid injections (CSI). However, CSI use in rotator cuff tendinopathy remains controversial, as prolonged corticosteroid exposure can lead to decreased tenocyte viability, alterations in collagen composition, and decreased tendon mechanical properties. Despite these known deleterious effects, CSIs are still commonly utilized in clinical practice, and there is no established consensus with regard to the timing and number of CSIs patients can receive. Determining the optimal injection strategy utilizing retrospective clinical data is challenging, given the heterogeneity of rotator cuff disease and the wide variety in injection practices. Previous pre-clinical studies have examined healthy and acutely transected rat rotator cuff tendons, but the consequences of CSI use have not been well-characterized in a murine rotator cuff tendinopathy model. The purpose of our study was to examine the structural, molecular, and functional effects of a single CSI versus multiple CSIs on murine rotator cuff tendons using a murine SAI model.
Methods:
The study protocol was approved by our institutional IACUC. Thirty 12-week-old male C57BL/6J mice underwent bilateral SAI surgery as previously described and were randomized into two groups. One group received bilateral subacromial CSI (triamcinolone acetonide, 4uL) on post-operative day 3, followed by subacromial sham saline injections on post-operative days 7, 14, and 21. The other group received bilateral subacromial CSIs at all post-operative timepoints. All mice were sacrificed 42 days post-operatively for histological analysis, biomechanical testing, and bulk RNA-seq. Supraspinatus tendons were evaluated histologically for tendinopathic changes using a semi-quantitative modified Bonar scoring system. Biomechanical testing evaluated supraspinatus tendon maximum load (N), maximum stiffness (N/mm), maximum stress (MPa), and maximum modulus (MPa). RNA isolation was performed on supraspinatus tendon samples using a Qiagen Kit, and then bulk RNA-seq was performed. Gait analysis (DigiGaitTM) was performed at baseline (pre-operatively) and on post-operative days 3, 7, 14, 21, and 42. Statistical analyses were conducted with GraphPad Prism software using unpaired t-tests for histology and biomechanical testing, as well as two-way ANOVA with Tukey's post-hoc test for gait analysis. The significance threshold was set at p < 0.05 for histology, biomechanics, and gait analysis. RNA-seq significance was set at FDR < 0.05.
Results:
On histology, the multiple CSI group had greater ground substance deposition and higher vascularity within the supraspinatus tendon (Fig. 1A,B). However, the total modified Bonar scores were not significantly different between the two groups. Tendons from the multiple CSI group were biomechanically weaker than the single CSI group, demonstrating significantly lower maximum force, maximum stiffness, and maximum modulus, although there was no difference in maximum stress (Fig. 1C). There was no significant difference in the stance/swing ratio on gait analysis (Fig. 2). The multiple CSI group had significantly longer stride length at 14 days and lower stride frequency on post-operative days 14 and 21 compared to the single CSI group (Fig. 2), but these gait differences resolved by the 42-day timepoint. At 42 days, the multiple CSI group showed significantly higher expression of pathways related to inflammation and innate immune system function, cell-cell communication and cell metabolism, and nociceptive signaling (Fig. 3).
Conclusions:
The results of this study demonstrate that multiple CSIs in the setting of rotator cuff tendinopathy may provide short-term functional benefits but can lead to deleterious structural and molecular changes to the tendon. These findings add to pre-clinical evidence which suggests CSIs, especially multiple injections over time, can have adverse effects on rotator cuff tendons. The multiple CSI group had significantly longer stride length and significantly lower stride frequency at intermediate timepoints, suggesting reduced pain with ambulation compared to the single injection group. However, there was no difference in stance/swing between groups at any timepoint, suggesting that any functional benefits associated with multiple CSIs were transient. Furthermore, the multiple CSI group had significantly higher expression of pathways related to inflammation, innate immune system function, and nociceptive signaling at 42 days. Our study highlights a key dilemma faced by physicians when treating rotator cuff tendinopathy: there is a trade-off between ameliorating pain and improving function in the short-term at the cost of potentially worsening long-term outcomes. Further research is needed to optimize injection strategies that alleviate symptoms without compromising tendon integrity.



